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Membrane fusion in exocytosis, intracellular trafficking, and enveloped viral infection is thought to be mediated by specialized proteins acting to 
merge membrane lipid bilayers. We now show that one class of naturally-occurring phospholipids, lysohpids, inhibits fusion between cell 
membranes, organelles, and between organelles and plasma membrane. Inhibition was reversible, did not correlate with lysis, and could be attributed 
to the molecular shape of lysolipids rather than to any specific chemical moiety. Fusion was arrested at a stage preceding fusion pore formation. 
Our results are consistent with the hypothesis that biological fusion, irrespective of trigger, involves the formation of a highly bent intermediate 
between membranes, the fusion stalk. 
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1. INTRODUCTION 
Because disparate biological fusion systems share 
structural, antigenic and functional traits, it has been 
proposed that they might also share a common mecha- 
nism and key fusion intermediates [l-4]. If these hypo- 
thetical common intermediates involve lipid molecules, 
the composition of membrane lipid bilayers may modu- 
late fusion reactions. In spite of an extensive literature 
on the role of lipid composition in the fusion of purely 
lipid bilayers [5], little is known about the lipid require- 
ments for biologically relevant fusion [6-81. 
Ca’+, GTP-y-S, GTP and H’, respectively. Our results 
reverse the long-held view that lysolipids promote bio- 
logically relevant fusion [15] and suggest he formation 
of stalk-type fusion intermediates as a possible common 
step in the different fusion processes. 
2. MATERIALS AND METHODS 
2.1. Lipi& and detergents 
Addition of lysophosphatidylcholine to the contact- 
ing monolayers of artificial planar lipid membranes was 
shown to inhibit their monolayer fusion [9]. Lysolipids, 
which have a molecular shape of an inverted cone, were 
hypothesized to increase the elastic energy of a highly 
bent stalk between membranes [9]. In the present paper 
we will show that lysolipids inhibit four diverse biolog- 
ical fusion processes: sea-urchin cortical granule exocy- 
tosis [lO,l 11, mast cell degranulation 1121, rat liver mi- 
crosome-microsome fusion [ 131 and syncytia formation 
of baculovirus infected insect cells [14] triggered by 
Lipids were purchased from Avanti Polar Lipids (Birmingham, 
AL), except for palmitic acid and glycerol monopalmitate which were 
purchased from Nucheck (Elysian, MN), and [?Z]palmitoyl LPC 
from Amersham (Arlington Heights, IL). Stock solutions were pre- 
pared as a 0.5% (w/w) aqueous dispersion. In some experiments lipid 
stock solutions were prepared as a sonicated dispersion or in ethanol 
at 50 mg/ml. All three procedures gave similar results. Detergents were 
purchased from Pierce (Rockford, IL) and prepared as an aqueous 
dispersion. 
2.2. Calcium induced fusion of sea urchin cortical granules 
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Granule exocytosis was followed using a light scattering assay in 
planar isolated sea urchin cortices [16], in cortical granule-cortical 
granule fusion [17], and in cell surface complex (CSC), prepared as 
described [18,19] from Lytechinurpictus eggs in PKME buffer (50 mM 
PIPES, pH 6.7,425 mM KCI, 10 mM MgC&, 5 mM EGTA). CSC’s 
were mixed with various concentrations of added lipids in a final 
volume of 100 ~1. One hundred microliters of either PKME buffer or 
PKME + calcium (final free calcium concentration was 330 PM) was 
added to each sample and the absorbance at 405 nm was measured 
by a microtiter-dish reader. Absorbance values were plotted as 
100 x (&nm with lipid + calcium) - (A405nm with lipid - calcium)/ 
(&nm no lipid + calcium) - (Awsn,,, no lipid - calcium). Absorbance 
of CSc’s in PKME with no lipids added was typically 0.4 OD. 
Abbreviations: GTP-7-S, guanosine 5’-O-(3-thiotriphosphate); CSC, 2.3. pH-induced fusion of insect cells infected by baculovirus 
cell surface complex; R-18, octadecyl rhodamine B; LPC, lyso- SF 9 insect cells (IO’ per well) were grown and infected with IO6 
phosphatidylcholine; PC, phosphatidylcholine; LPE, lysophosphati- pfu/ml wild-type baculovirus AcNPV as described [14]. Fusion was 
dylethanolamine; PEG, polyethylenglycol. triggered by incubating the cells for 10 min in medium at pH 5.0. 
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Following the incubation, the buffer was replaced with normal pH 6.4 
medium. To study the effects of lysolipids on fusion, cells were incu- 
bated in 0.5 ml either in the presence or absence of lysolipids for 15 
min (5 min before and IO min during low pH treatment of cells). After 
one hour, the ratio of nuclei within syncytia to the total number of cell 
nuclei in the same field was counted as described [141. 
2.4. GTP-dependent fusion of rat liver mlcrosomes 
Fusion was detected in the fusion system previously described [14 
by an octadecyf rhodamine B chloride (R 18) fluorescence dequench- 
ing assay 1201, except that the final concentrations of microsomal 
protein, GTP and Mg2’, were 0.22 mg/ml, 194 ,uM, and 0.98 mM, 
respectively. Microsome suspensions (204 ~1) were incubated with 
exogenous lipids for 3 min at 37’C before GTP was added to trigger 
fusion. Dequenching of R 18 was not observed in the absence of GTP. 
Maximum dequenching was determined after solubilization of mem- 
branes wtth 2% Triton X-100. The rates of fusion were obtained by 
a linear regression analysis of the initial portions of the dequenching 
kinetic curves. 
2.5. GTP-y-S-triggered exocytosis in Beige mouse mast cells 
Mast cells were obtained from female Beige mice (C57BL/6N-bg) 
by peritoneal avage, and cell degranulation triggered by 10 ,uM of 
GTP-y-S was studied as described [21]. To measure membrane capac- 
itance we applied sinusoidally varying voltage with 1 kHz frequency 
and 50 mV peak-to-peak amplitude. 
3. RESULTS AND DISCUSSION 
The addition of exogenous lysolipids to the medium 
resulted in fast (within 5 min) and dose-dependent inhi- 
bition of cortical granule exocytosis, baculovirus in- 
fected cell-cell fusion, and microsome-microsome fu- 
sion (Fig. la). This inhibition did not depend upon the 
choice of experimental assay or preparation: we meas- 
ured similar dose-response curves of inhibition by LPC, 
in cell surface complex exocytosis (Fig. la), isolated 
planar cortex exocytosis (see below). and isolated corti- 
cal granule co-fusion ([17] (n = 2, data not shown). 
Inhibition was also observed in patch clamp studies 
of GTP-F-S triggered exocytosis in mast cell. Inclusion 
of LPC in the pipette internal solution inhibited the 
usual step-wise changes in capacitance which corre- 
spond to single degranulation events (Fig. 1 b). In 13 out 
of 15 experiments, in the absence of LPC, the first fusion 
event occurred in less than 5 min with an average delay 
time of 2 min. In the presence of LPC there was no 
fusion in 13 out of 16 experiments (cells were observed 
for at least 5-10 min), In the remaining 3 cells, the first 
fusion event occurred on average 4.5 min after estab- 
lishment of whole-cell configuration. 
The concentrations of LPC needed for inhibition var- 
ied significantly between experimental systems tudied. 
This variation, and, in particular, the si~ificantly 
higher concentrations required for inhibition of cell-cell 
fusion can be explained by differences in the amount of 
biological material present, rate of lipid metabolism, 
and/or composition of membranes (including the differ- 
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Fig. 1. Inhibition of biological membrane fusion by lysolipids. Panel 
A: lysolipid-induced inhibition of calcium-triggered cortical exocyto- 
sis (oleoyl LPC (0). oleoyl lysophosphatidylethanolamine, LPE (17)); 
pH-induced fusion of insect cells infected by baculovirus (oleoyl LPC 
CO)); GTP-dependent fusion of rat liver microsomes (oleoyl LPC (m)). 
Membrane fusion was assayed as described below. Each point is 
mean f SE., n = 3. normalized to fusion response in the absence of 
exogenous lipid. Added LPC did not change the buffer free calcium 
or pH (not shown). Panel B: capacitance traces of mast cells m the 
presence and absence of 9.6 PM oleoyl LPC in the pipette solution. 
The time at which the whole-cell configuration was established is taken 
as zero. 
Since transient changes in membrane capacitance 
were not detected in LPC-treated mast cells, and de- 
quenching of membrane dye was not detected with 
LPC-treated microsomes, we conclude that lysolipids 
arrest fusion at a stage preceding the formation of small 
pores which allow aqueous and lipid transfer. 
For inhibition, LPC had to be added to the aqueous 
space between fusing membranes; when added to media 
external to mast cells, but not in the patch pipette, inhi- 
bition was not observed (n = 10). 
LPC was previously thought to cause membrane fu- 
sion, but this was observed only at higher, lytic concen- 
trations [I 51. Inhibition of fusion did not correlate with 
lysis in our systems. For example, we measured a de- 
crease in turbidity due to microsome lysis only above 
200 PM palmitoyl LPC, while 9.3 PM LPC gave 50% 
inhibition of fusion (Fig. 2a). For different lysolipids 
and experimental systems the ratios between the lysol- 
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Fig. 2. LPC induced inhibition of fusion correlates with binding but 
not membrane lysis, and is completely reversible. A. Microsome fusion 
(0) was assayed as described above (n = 3). Subsequent to a 10 min 
incubation, palmitoyl LPC binding (0) was determined by centrtfuga- 
tion of microsomes at 10,000 x g for 5 min and measurement of the 
distribution of [‘4C]palmitoyl LPC between microsome pellet and su- 
pernatant (n = 2). Lysis of microsomes (0) was detected by measuring 
the turbidity of the incubation mixture at 490 nm, normalized to the 
turbidity decrease after addition of 2% Triton Xl00 (n = 3). All points 
are mean + SE. B. Bar I shows the percent of granules in the sea 
urchin cortex fusing in response to perfusion with PKME buffer con- 
taining 313 PM calcium. If the cortex was first incubated with PKME 
containing 32pM myristoyl LPC, there was no change in light scatter- 
ing following perfusion with calcium (II). If the cortex was first treated 
with myristoyl LPC, then washed with 3 ml of PKME buffer to remove 
cortex associated LPC, and finally perfused with a buffer containing 
313 PM free calcium, we saw a complete recovery of fusion activity 
(III). All points are mean + S.E., n = 3. If we used 48pM oleoyl LPC 
to inhibit fusion, we found that washing with even 10 ml of PKME 
did not reverse the inhibition (data not shown). In contrast, washing 
with 1 ml of PKME containing 2 mg/ml of delipidated bovine serum 
albumin to extract lysolipids from membranes 1321 resulted m a 
47 + 20% (n = 3) recovery of fusion activity. 
ipid concentration required to observe the onset of lysis 
and that causing more than 50% inhibition of fusion 
varied from 1.2 to >20 (see Table I). 
Experiments with synthetic non-ionic surfactants 
have shown that the inhibition is not caused by any 
products of lysolipid biological degradation or transfor- 
mation and supported the suggestion that an inverted 
cone shape of the amphiphile molecule rather than a 
specific chemical group is responsible for the inhibition. 
Tween 80 has the same oleate hydrophobic tail as oleoyl 
LPC, and a relatively large polar head whose structure 
is quite different from that of LPC (see Table I). At 
concentrations much below those which cause lysis, 
Tween 80 reversibly inhibited fusion in the two systems 
tested suggesting a common mechanism with lysolipids 
for inhibition. Lauroyl derivative of the same surfac- 
tant, Tween 20, also inhibited fusion. In contrast, Span 
20, having a molecular shape closer to cylindrical than 
that of Tween 20, caused no inhibition. 
LPC-induced inhibition was completely reversible. There was no correlation between the lysolipid con- 
Isolated planar sea urchin cortices were perfused with centration required for inhibition and lysolipid critical 
solutions containing enough myristoyl LPC to inhibit micelle concentration (CMC). For example, lauroyl and 
fusion (Fig. 2b). When the LPC-treated cortices were stearoyl LPC inhibited fusion below and above their 
washed with calcium-free solutions, subsequent perfu- CMC’s respectively (Fig. 3). These results, together with 
sion with solutions containing 313 PM calcium led to the aforementioned observation that fusion competence 
complete fusion. In contrast, the fusion competence of was hard to restore by perfusion in the case of longer 
cortices treated with oleoyl LPC could be restored only hydrocarbon chain lysolipids, did not prove but sug- 
by perfusion with buffer containing delipidated bovine gested that inhibition was caused by the LPC incorpo- 
serum albumin. Presumably, oleoyl LPC is harder to 
extract from membranes because of its longer hydrocar- 
bon chain [22]. Inhibition of pH induced syncytia for- 
mation by myristoyl LPC was also completely reversible 
(data not shown, n = 3). Thus, we can exclude solubili- 
zation and irreversible denaturation of cellular compo- 
nents as possible mechanisms of this inhibition. 
We varied the chemical moieties of lysolipid to deter- 
mine which were responsible for inhibition of fusion 
(Table I). Inhibition was observed for different combi- 
nations of hydrocarbon chains and polar heads. Since 
both charged and zwitterionic lysolipids suppressed fu- 
sion, the inhibition is not due to electrostatic interac- 
tions as described [23]. 
Different lipids have different molecular shapes in 
membranes and can be separated into three groups: 
cones, cylinders and inverted cones, on the basis of 
comparing the surface area of the lipid polar head with 
the area of a cross-section of hydrocarbon tail [24]. All 
the compounds in Table I which inhibited membrane 
fusion are micelle-forming amphiphiles and have the 
shape of inverted cones, i.e. they have large polar heads 
and small hydrophobic tails. Dioleoyl phosphati- 
dylcholine (PC) differs from oleoyl LPC by one chain, 
yet it did not inhibit fusion either because of its cylindri- 
cal shape [25] or because it did not incorporate into the 
membrane [26]. However, even dicapryl PC (cylinder) 
and palmitic acid (cone), which readily incorporate into 
membranes [27,28] were not potent inhibitors. In any 
case, the lack of inhibiting activity of PC suggests that 
head group binding is not responsible for LPC inhibi- 
tion. 
73 
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rated into membranes. We determined that 1.2 ,uM of 
palmitoyl LPC bound/mg microsome protein resulted 
in 50% inhibition. The binding constant of LPC to mi- 
crosomes was - IO6 M-r, close to that published [22] for 
erythrocytes, -3 x lo5 M-l, but we do not know if this 
value corresponds to membrane incorporated LPC or 
just bound. 
One possible explanation for how amphipathic mole- 
cules inhibit triggered membrane fusion is that they 
bind to crucial protein components of the fusion ma- 
chinery. While we cannot eliminate the possibilities of 
a direct action of lysolipids on a fusion protein, such as 
binding to proposed hydrophobic fusion peptides, the 
wide range of biological systems inhibited, including 
myoblast fusion [27], suggests a physicochemical mech- 
anism of inhibition common to all the systems tudied, 
perhaps reiated to properties of membrane lipids. LPC 
promotes the later stage of phosphoIipid bilayer fusion, 
TABLE 1 
FUSlON fNHfL%ITlON AND LYSfS IN FRESENCE OFDIFFERENT AMPHH’HILES 
Bmlogirsl Amphiphilcs 
al*-- a-- C-H, 
R = Lauroyl for Span 20 
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Fig. 3. Membrane fusion inhibited by lysolipids both below and above their CMC. Dose-response curves for (A) lauroyl LPC (sea urchin cortices) 
and (B) stearoyl LPC (sea urchin CSCs). All points are mean + S.E., n = 3. The CMC values (vertical dotted lines) for lauroyl and stearoyl LPC 
are 430 ,uM and 0.4 PM, respectively [33]. 
the joining of aqueous compartments, when incorpo- 
rated into distal leaflets of contacting planar mem- 
branes [28], and in the case of PEG-induced fusion of 
liposomes [29]. However, adding LPC between two pla- 
nar lipid bilayers inhibits monolayer fusion, an early 
stage of fusion in these membranes [93. The incorpora- 
tion of micellar (inverted cone) molecules into contact- 
ing monolayers is hypothesized [9] to restrict formation 
of a highly curved stalk, a fusion intermediate [9,28] 
which connects two membranes. Biological membranes 
may also require local bending of monolayers to form 
fusion intermediates. Alternatively, an increase in sur- 
face area of contacting membrane leaflets, resulting 
from asymmetric intercalation of lysolipids, may cause 
inhibition through compression of proteins and buck- 
ling of membranes. Consistent with these physicochem- 
ical mechanisms, we have shown that many micelle- 
forming substances can inhibit biological membrane fu- 
sion, regardless of the specific chemical moieties they 
contain. Indeed, other membrane active compounds 
such as amphipathic peptides, local anesthetics, spermi- 
tides and surfactants may inhibit membrane fusion in 
a similar way. 
We conclude that lysolipids, considered for a long 
time as putative biological fusogens [15], do not pro- 
mote but, in contrast, reversibly inhibit four different 
fusion reactions including both viral fusion and granule 
exocytosis. If the introduction of lysolipids into contact- 
ing leaflets inhibits membrane fusion by preventing for- 
mation of curved fusion intermediates uch as stalks 
[9,28], our data suggest hat these lipid-involving inter- 
mediates are common between disparate processes of 
biological membrane fusion. Because lysolipids are 
tightly regulated biological compounds [30], present in 
nearly all biological membranes analyzed [31], it is in- 
triguing to speculate that cells control local lysolipid 
concentrations to regulate fusion processes. 
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